ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
2024 ANS Annual Conference
June 16–19, 2024
Las Vegas, NV|Mandalay Bay Resort and Casino
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Apr 2024
Jan 2024
Latest Journal Issues
Nuclear Science and Engineering
May 2024
Nuclear Technology
Fusion Science and Technology
Latest News
Former Exelon CEO Chris Crane remembered for “transformational milestones”
Crane
Exelon announced that Chris Crane, the company’s former chief executive, passed away on Saturday in Chicago at the age of 65.
Crane served as the company’s president and CEO from 2012 until his retirement in December 2022. During his tenure, he steered the energy company through several transformational milestones, including the successful mergers with Constellation Energy in 2012 and Pepco Holdings in 2016, creating the largest utility business by customer count in the United States.
In 2022, with the spin-off of Constellation as the generation and retail side of energy business (with the largest U.S. nuclear fleet), Crane led the creation of a stand-alone transmission and delivery energy company.
Z. Z. Johal, J. W. Crippen, A. C. Forsman, E. H. Lundgren, K. A. Moreno, A. Nikroo
Fusion Science and Technology | Volume 55 | Number 3 | April 2009 | Pages 331-336
Technical Paper | Eighteenth Target Fabrication Specialists' Meeting | doi.org/10.13182/FST08-3503
Articles are hosted by Taylor and Francis Online.
The National Ignition Facility (NIF) tuning and ignition capsules will be gas filled through a laser precision drilled hole with a fill tube attached. To field these targets, several physics and assembly requirements must be met. These requirements drive the morphology of the final capsule and fill tube assembly (CFTA). Unexpectedly, they have also driven the need for a fill tube-transition tube subassembly, which is significant in the extra time required for fabrication. We have implemented engineering solutions that allow successful fabrication, testing, and transportation of CFTAs. During fabrication the fill tube is vertically inserted into both the transition tube and capsule, it is adhered with a low-viscosity adhesive, and there is a gap between mating surfaces. Nitrogen backpressure is flowed through the transition tube to prevent wicking of adhesive into the fill tube and to prevent partial restriction of flow or plugging. A nitrogen purge has also been implemented to displace atmospheric oxygen, which would otherwise absorb into the adhesive surface, truncate the polymerization process, and lead to a partially cured joint. Prior to transportation, the CFTA must complete a series of testing that simulates final assembly and NIF conditions: (a) helium leak test at room temperature, (b) helium leak test at liquid nitrogen temperature, (c) pressure test, and (d) X-ray fluorescence testing. The CFTA is transported in a custom device that provides vital support for the fill tube-to-capsule interface.